George BandarianAI Innovator & Venture Leader Driving Future Technologies

The Company Running More Clinical Trials Than the FDA - With AI

Name: The Company Running More Clinical Trials Than the FDA - With AI
Uploaded: 2026-06-30T21:30:32+00:00
Duration: 1 min 47 s
Channel: George Bandarian
Description: The speaker identifies a core bottleneck across pharma, food, beverage, and dietary supplement industries: the inability to generate rigorous, scalable…

30 Jun 2026 · 2 min

Watch on YouTube

1:47

The speaker identifies a core bottleneck across pharma, food, beverage, and dietary supplement industries: the inability to generate rigorous, scalable clinical evidence for products intended for complex human use. Traditional approaches rely on animal studies or AI predictions, but translating these to real-world human outcomes stalls development. To address this, the speaker’s startup reimagines clinical trials by removing inefficiencies and automating most steps with AI agents, deploying them directly into participants’ homes. Leveraging a citizen‑science model, the company conducts trials on products that are already presumed safe, eliminating the need for hospital‑based monitoring and enabling rapid, large‑scale data collection. The founder’s background includes running clinical trials at UCLA, which informed the redesign. The go‑to‑market focuses on the food, beverage, and supplement sectors—areas historically lacking access to rigorous trials—targeting medium and large consumer companies. Notable clients such as Unilever, PepsiCo, and Procter & Gamble now receive real health data on their products through these decentralized trials.

Chapters

Essentially, the biggest problem that has really prevented pharma from scalably developing drugs or food companies from creating truly measurably better-for-you foods or dietary supplement companies from creating truly efficacious products is they all are missing the ability to generate rigorous clinical evidence on any efficient manner. So that's where everything gets stuck. We can do rat studies. We can do AI prediction models. But the second you want to actually put it into complex human beings living in a complex world, that's where everything comes to a grinding halt. So when we started the company, we said, OK, what's it going to take to create a universe of proven precision health treatments? You've got to solve the clinical evidence piece. So the initial go-to-market for us was, let's effectively reinvent how trials are done. And let's serve a sector that hasn't really had access to trials, which is the food, beverage, and supplement categories. So we basically took everything that you come to know. I used to run clinical trials at UCLA, and you basically— we took out every inefficiency, and we automated most of the steps with AI agents, and we brought them into the homes of the people in the stu— in the trials. So it's citizen science, and you're studying real people in real environments. And because the things that we're studying are already presumably safe, you now no longer need strict medical monitoring in hospitals to administer these. So, now you can scale really rapidly. So, we started serving medium and large size companies, and for the first time ever, they're now able to generate real health data on their products. So, like our clients are, you know, Unilever and PepsiCo and P&G and all these big companies, and we're effectively running trials on their products.